Panfeng Shang

10PUBLICATIONS

3CO-AUTHORS

Terahertz physicsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 01, 2026

Caution in interpreting the diagnostic superiority of digital Uromonitor in NMIBC surveillance.

|Mar 14, 2026

Angiogenesis-Informed Preoperative CT Radiogenomics Predicts Overall Survival in Clear Cell Renal Cell Carcinoma: Development and External Validation.

Yanghuang Zheng, Yuelin Du, Zhongwei Ma

|Mar 02, 2026

A FOXO1-G6PC transcriptional axis restrains renal cell carcinoma progression: multi-omics, epigenetic, and mechanistic evidence.

Jieneng Wang, Bin Zhang, Hualan Ha

|Feb 13, 2026

TREM2 in Urological Malignancies and Benign Lesions: Mechanistic Convergence, Functional Heterogeneity, and Translational Perspectives: A Narrative Review.

Yu Dai, Yaqiang Feng, Cheng Wang

|Jul 14, 2025

High FSTL1 expression promotes bladder cancer progression by enhancing tumor cell migration.

Helin Zhang, Xingxing Zhang, Yuelin Du

|Apr 24, 2024

Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.

Helin Zhang, Xingxing Zhang, Yuelin Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Qian Hou

2 joint publications

Biao Zhang

1 joint publications

Juanyao Liu

Frequent Collaborators

2 joint publications

Qian Hou

2 joint publications

Biao Zhang

1 joint publications

Juanyao Liu